Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.79M | 6.86M | -- | -- | -- |
| Depreciation & Amortization | 29.80K | 31.00K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.30M | 7.23M | -- | -- | -- |
| Operating Income | -13.30M | -7.23M | -- | -- | -- |
| Income Before Tax | -13.63M | -7.20M | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.63 | -7.20 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.63M | -7.20M | -- | -- | -- |
| EBIT | -13.30M | -7.23M | -- | -- | -- |
| EBITDA | -13.27M | -7.20M | -- | -- | -- |
| EPS Basic | -0.59 | -0.39 | -- | -- | -- |
| Normalized Basic EPS | -0.37 | -0.25 | -- | -- | -- |
| EPS Diluted | -0.59 | -0.39 | -- | -- | -- |
| Normalized Diluted EPS | -0.37 | -0.25 | -- | -- | -- |
| Average Basic Shares Outstanding | 85.87M | 73.00M | -- | -- | -- |
| Average Diluted Shares Outstanding | 85.87M | 73.00M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |